Intravenous ghrelin administration enhances gastric acid secretion - Evaluation using wireless pH capsule

M. Mori, Hidekazu Suzuki, Tatsuhiro Masaoka, H. Imaeda, Y. Nomoto, H. Hosoda, T. Nishizawa, K. Kangawa, T. Hibi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Ghrelin, a recently discovered peptide hormone, has been shown to be produced mainly by the A-like cells of the gastric mucosa. Ghrelin not only stimulates growth hormone (GH) release but also promotes gastric motility. While the effect of ghrelin on the gastric acid secretion in rats has been reported, no such reports appeared to date from studies in humans. Aim: To investigate the effect of ghrelin administration on the gastric pH in humans, using a novel wireless pH capsule (Bravo, Medtronic, Shoreview, MN, USA). Methods: Four healthy volunteers (male; average age, 35.0 years; Helicobacter pylori-negative) were enrolled. The pH capsule was attached endoscopically to the gastric mucosa and the data were transmitted to a portable receiver. Thirty minutes after a stabilization period, synthetic ghrelin (5 μg/kg body weight) was injected intravenously into the subjects and the data were monitored for more than 120 min while the subjects lay supine. Results: The average minimum gastric pH in four cases (1.2 ± 0.10) was significantly decreased after injection of ghrelin, as compared with the basal pH value (1.8 ± 0.06). The serum gastrin level, however, showed no change after the ghrelin injection. Conclusion: These results suggest that exogenous ghrelin could enhance gastric acid secretion in humans.

Original languageEnglish
Pages (from-to)96-103
Number of pages8
JournalAlimentary Pharmacology and Therapeutics
Volume24
Issue numberSUPPL.4
DOIs
Publication statusPublished - 2006 Dec

Fingerprint

Ghrelin
Gastric Acid
Intravenous Administration
Capsules
Stomach
tetrachloroisophthalonitrile
Gastric Mucosa
Injections
Peptide Hormones
Gastrins
Helicobacter pylori
Growth Hormone
Healthy Volunteers
Body Weight
Serum

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Intravenous ghrelin administration enhances gastric acid secretion - Evaluation using wireless pH capsule. / Mori, M.; Suzuki, Hidekazu; Masaoka, Tatsuhiro; Imaeda, H.; Nomoto, Y.; Hosoda, H.; Nishizawa, T.; Kangawa, K.; Hibi, T.

In: Alimentary Pharmacology and Therapeutics, Vol. 24, No. SUPPL.4, 12.2006, p. 96-103.

Research output: Contribution to journalArticle

Mori, M. ; Suzuki, Hidekazu ; Masaoka, Tatsuhiro ; Imaeda, H. ; Nomoto, Y. ; Hosoda, H. ; Nishizawa, T. ; Kangawa, K. ; Hibi, T. / Intravenous ghrelin administration enhances gastric acid secretion - Evaluation using wireless pH capsule. In: Alimentary Pharmacology and Therapeutics. 2006 ; Vol. 24, No. SUPPL.4. pp. 96-103.
@article{244e5ba6459947458c4391e6769469b9,
title = "Intravenous ghrelin administration enhances gastric acid secretion - Evaluation using wireless pH capsule",
abstract = "Background: Ghrelin, a recently discovered peptide hormone, has been shown to be produced mainly by the A-like cells of the gastric mucosa. Ghrelin not only stimulates growth hormone (GH) release but also promotes gastric motility. While the effect of ghrelin on the gastric acid secretion in rats has been reported, no such reports appeared to date from studies in humans. Aim: To investigate the effect of ghrelin administration on the gastric pH in humans, using a novel wireless pH capsule (Bravo, Medtronic, Shoreview, MN, USA). Methods: Four healthy volunteers (male; average age, 35.0 years; Helicobacter pylori-negative) were enrolled. The pH capsule was attached endoscopically to the gastric mucosa and the data were transmitted to a portable receiver. Thirty minutes after a stabilization period, synthetic ghrelin (5 μg/kg body weight) was injected intravenously into the subjects and the data were monitored for more than 120 min while the subjects lay supine. Results: The average minimum gastric pH in four cases (1.2 ± 0.10) was significantly decreased after injection of ghrelin, as compared with the basal pH value (1.8 ± 0.06). The serum gastrin level, however, showed no change after the ghrelin injection. Conclusion: These results suggest that exogenous ghrelin could enhance gastric acid secretion in humans.",
author = "M. Mori and Hidekazu Suzuki and Tatsuhiro Masaoka and H. Imaeda and Y. Nomoto and H. Hosoda and T. Nishizawa and K. Kangawa and T. Hibi",
year = "2006",
month = "12",
doi = "10.1111/j.1365-2036.2006.00031.x",
language = "English",
volume = "24",
pages = "96--103",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "SUPPL.4",

}

TY - JOUR

T1 - Intravenous ghrelin administration enhances gastric acid secretion - Evaluation using wireless pH capsule

AU - Mori, M.

AU - Suzuki, Hidekazu

AU - Masaoka, Tatsuhiro

AU - Imaeda, H.

AU - Nomoto, Y.

AU - Hosoda, H.

AU - Nishizawa, T.

AU - Kangawa, K.

AU - Hibi, T.

PY - 2006/12

Y1 - 2006/12

N2 - Background: Ghrelin, a recently discovered peptide hormone, has been shown to be produced mainly by the A-like cells of the gastric mucosa. Ghrelin not only stimulates growth hormone (GH) release but also promotes gastric motility. While the effect of ghrelin on the gastric acid secretion in rats has been reported, no such reports appeared to date from studies in humans. Aim: To investigate the effect of ghrelin administration on the gastric pH in humans, using a novel wireless pH capsule (Bravo, Medtronic, Shoreview, MN, USA). Methods: Four healthy volunteers (male; average age, 35.0 years; Helicobacter pylori-negative) were enrolled. The pH capsule was attached endoscopically to the gastric mucosa and the data were transmitted to a portable receiver. Thirty minutes after a stabilization period, synthetic ghrelin (5 μg/kg body weight) was injected intravenously into the subjects and the data were monitored for more than 120 min while the subjects lay supine. Results: The average minimum gastric pH in four cases (1.2 ± 0.10) was significantly decreased after injection of ghrelin, as compared with the basal pH value (1.8 ± 0.06). The serum gastrin level, however, showed no change after the ghrelin injection. Conclusion: These results suggest that exogenous ghrelin could enhance gastric acid secretion in humans.

AB - Background: Ghrelin, a recently discovered peptide hormone, has been shown to be produced mainly by the A-like cells of the gastric mucosa. Ghrelin not only stimulates growth hormone (GH) release but also promotes gastric motility. While the effect of ghrelin on the gastric acid secretion in rats has been reported, no such reports appeared to date from studies in humans. Aim: To investigate the effect of ghrelin administration on the gastric pH in humans, using a novel wireless pH capsule (Bravo, Medtronic, Shoreview, MN, USA). Methods: Four healthy volunteers (male; average age, 35.0 years; Helicobacter pylori-negative) were enrolled. The pH capsule was attached endoscopically to the gastric mucosa and the data were transmitted to a portable receiver. Thirty minutes after a stabilization period, synthetic ghrelin (5 μg/kg body weight) was injected intravenously into the subjects and the data were monitored for more than 120 min while the subjects lay supine. Results: The average minimum gastric pH in four cases (1.2 ± 0.10) was significantly decreased after injection of ghrelin, as compared with the basal pH value (1.8 ± 0.06). The serum gastrin level, however, showed no change after the ghrelin injection. Conclusion: These results suggest that exogenous ghrelin could enhance gastric acid secretion in humans.

UR - http://www.scopus.com/inward/record.url?scp=33846066424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846066424&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2006.00031.x

DO - 10.1111/j.1365-2036.2006.00031.x

M3 - Article

AN - SCOPUS:33846066424

VL - 24

SP - 96

EP - 103

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - SUPPL.4

ER -